Chemotherapy Chair Market - By Product Type: Manual Chemotherapy Chairs, Electric/Motorized Chemotherapy Chairs, Semi-Automatic Chairs; By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Oncology Clinics, Home Healthcare; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global chemotherapy chair market is steadily growing, fueled by the increasing rate of cancer cases and the rising need for outpatient chemotherapy services. Chemotherapy chairs are specially created for patient comfort during extended infusion sessions, providing features such as adjustable positioning, ergonomic support, electronic controls, and accessories for IV poles and monitors.
The shift toward ambulatory and home-based cancer care, along with advances in chair ergonomics and smart features such as motorized control, patient monitoring, and infection-resistant materials, is driving market growth. The increasing demand for patient-centered healthcare facilities further boosts investments in modern chemotherapy chair solutions.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
0.67 |
Historical benchmark |
|
2024 |
1.06 |
Five-year CAGR 9.6% |
|
2031 |
2.34 |
Seven-year CAGR 11.9% |
The market is expected to more than double by 2031, driven by the rise in cancer patients and increasing investments in ambulatory infusion centers.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The chemotherapy chair market is somewhat competitive, with both global and regional companies providing a variety of manual, semi-automated, and fully motorized chairs.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Bristol Maid |
18% |
Chemotherapy Recliner Series, height-adjustable chairs |
|
Champion Manufacturing |
17% |
54 Series Medical Recliner, Ascent™ recliners |
|
Hillrom (Baxter) |
16% |
Procedural Recliner Chairs |
|
GF Health Products |
13% |
Lumex® Recliners |
|
Others (Lojer, Steelcase Health, Technoavia, regional OEMs) |
36% |
Manual and specialty chairs |
6 | Market Segmentation
By Product Type:
By End User:
By Region:
7 | Strategic Outlook
Future growth will focus on AI-powered patient monitoring integrated into chemotherapy chairs, IoT-enabled equipment for remote control, and advanced materials designed for infection control and increased patient comfort. Expansion in emerging markets is expected due to rising cancer rates and growing investments in oncology infrastructure.
Need help?
Chat with our team in a minute.